NeoGenomics Inc (STU:NG9)
€ 12.6 -0.1 (-0.79%) Market Cap: 1.76 Bil Enterprise Value: 1.96 Bil PE Ratio: 0 PB Ratio: 1.97 GF Score: 76/100

Q1 2022 Neogenomics Inc Earnings Call Transcript

Apr 27, 2022 / 12:30PM GMT
Release Date Price: €10.33 (-2.86%)
Operator

Good morning, ladies and gentlemen, thank you for standing by. Welcome to the NeoGenomics First Quarter 2022 Earnings Call. (Operator Instructions)

I would now like to turn the call over to the host, Executive Chair of NeoGenomics, Lynn Tetrault. Please go ahead.

Lynn A. Tetrault;Charlie Eidson
NeoGenomics, Inc. - Executive Chairman & Principal Executive Officer;NeoGenomics, Inc. - Director of IR and

Thank you, Kelly, and good morning. I'd like to welcome everyone to NeoGenomics First Quarter 2022 Conference Call. Joining me for this call from our Fort Myers Headquarters are Bill Bonello, our Chief Financial Officer; Doug Brown, our Chief Strategy and Corporate Development Officer; and Charlie Eidson, our Director of Investor Relations. Joining on the call via phone is Dr. Shashi Kulkarni, our Chief Scientific Officer and Executive Vice President of Research and Development.

Before we begin our prepared remarks, Charlie will discuss the forward-looking statements and non-GAAP measures used on this call.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot